196 related articles for article (PubMed ID: 20087052)
1. [Combination of S-1 and paclitaxel for advanced/recurrent gastric cancer patients with peritoneal metastasis, feasibility study (OGSG0401)].
Kimura Y; Machida H; Fujitani K; Yamamoto M; Tominaga K; Yano H; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Gan To Kagaku Ryoho; 2010 Jan; 37(1):151-5. PubMed ID: 20087052
[TBL] [Abstract][Full Text] [Related]
2. [Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
Ohashi M; Kanda T; Yajima K; Banba T; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1640-2. PubMed ID: 16315894
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer.
Narahara H; Fujitani K; Takiuchi H; Sugimoto N; Inoue K; Uedo N; Tsukuma H; Tsujinaka T; Furukawa H; Taguchi T
Oncology; 2008; 74(1-2):37-41. PubMed ID: 18544958
[TBL] [Abstract][Full Text] [Related]
4. [Two advanced gastric cancer cases with peritoneal metastases successfully treated by s-1/paclitaxel combination therapy].
Ina K; Furuta R; Kataoka T; Nishio T; Nagao S; Kayukawa S; Masaki A; Ando T; Goto H
Gan To Kagaku Ryoho; 2009 Jun; 36(6):979-81. PubMed ID: 19542719
[TBL] [Abstract][Full Text] [Related]
5. [Strategy of treatment for gastric cancer with peritoneal metastasis].
Tanemura H; Oshita H; Yamada M; Hatoh T; Adachi T; Matsui K
Gan To Kagaku Ryoho; 2010 Mar; 37(3):443-6. PubMed ID: 20332680
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.
Inada S; Tomidokoro T; Fukunari H; Sato T; Hatano T; Nishimura A; Kawauchi Y; Nikkuni K; Shimizu T; Sato T; Yanagi M; Takahashi S; Yoshida H; Sugita M; Hayashi T
Cancer Chemother Pharmacol; 2009 Jan; 63(2):267-73. PubMed ID: 18379784
[TBL] [Abstract][Full Text] [Related]
7. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH
Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of a combination of s-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.
Ueda Y; Yamagishi H; Ichikawa D; Morii J; Koizumi K; Kakihara N; Shimotsuma M; Takenaka A; Yamashita T; Kurioka H; Nishiyama M; Morita S; Nakamura K; Sakamoto J
Oncology; 2005; 69(3):261-8. PubMed ID: 16138002
[TBL] [Abstract][Full Text] [Related]
9. A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer.
Hokita S; Aikou T; Miyazono F; Ishigami S; Aridome K; Maenohara S; Saihara T; Suenaga K; Nomura H; Maeda S; Takatori H; Arima H; Uchikado Y; Natsugoe S; Takao S
Cancer Chemother Pharmacol; 2006 Jun; 57(6):736-40. PubMed ID: 16163539
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy].
Hatori S; Kunisaki C; Ono H; Sato T; Otsuka Y; Yamada R; Ohshima T; Rino Y; Imada T
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1257-60. PubMed ID: 16969021
[TBL] [Abstract][Full Text] [Related]
11. [A case of advanced gastric cancer with Schnitzler's metastases effectively treated by the combination of paclitaxel and S-1].
Yamamoto M; Matsuyama A; Kameyama T; Okamoto M; Okazaki J; Utsunomiya T; Tsutsui S; Ishida T
Gan To Kagaku Ryoho; 2008 May; 35(5):829-31. PubMed ID: 18487923
[TBL] [Abstract][Full Text] [Related]
12. A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.
Nakajo A; Hokita S; Ishigami S; Miyazono F; Etoh T; Hamanoue M; Maenohara S; Iwashita T; Komatsu H; Satoh K; Aridome K; Morita S; Natsugoe S; Takiuchi H; Nakano S; Maehara Y; Sakamoto J; Aikou T;
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1103-9. PubMed ID: 18317763
[TBL] [Abstract][Full Text] [Related]
13. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Yamashita H; Watanabe T
Cancer; 2013 Sep; 119(18):3354-8. PubMed ID: 23798046
[TBL] [Abstract][Full Text] [Related]
14. [A case of advanced gastric cancer treated with S-1 and S-1/paclitaxel showing complete response twice].
Matsuyama J; Naitou A; Hiraki M; Matsumoto S; Hashimoto K; Yokoyama S; Morita S; Morimoto T; Fukushima Y; Nishishou I; Nomura T; Sasaki Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2297-9. PubMed ID: 20037401
[TBL] [Abstract][Full Text] [Related]
15. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
[TBL] [Abstract][Full Text] [Related]
16. [A case of gastric cancer with posterior mediastinal lymph node metastasis responding to combination therapy of Paclitaxel and S-1].
Naito M; Shinohara T; Ishii F; Shibata R; Yamaguchi R; Maki K; Hoshino S; Tanaka S; Yamashita Y
Gan To Kagaku Ryoho; 2009 Sep; 36(9):1553-6. PubMed ID: 19755832
[TBL] [Abstract][Full Text] [Related]
17. [A phase I study of combination chemotherapy using TS-1 and weekly paclitaxel for advanced gastric cancer].
Fujiwara Y; Fujita J; Kan K; Tsukahara K; Takiguchi S; Miyata H; Yasuda T; Doki Y; Monden M
Gan To Kagaku Ryoho; 2006 Jan; 33(1):45-8. PubMed ID: 16410697
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of S-1 for resectable gastric cancer with peritoneal seeding.
Fujitani K; Tsujinaka T; Hirao M
Hepatogastroenterology; 2003; 50(51):889-92. PubMed ID: 12828112
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
20. A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for Advanced Stomach Cancer (TASC).
Morita S; Baba H; Tsuburaya A; Takiuchi H; Matsui T; Maehara Y; Sakamoto J
Jpn J Clin Oncol; 2007 Jun; 37(6):469-72. PubMed ID: 17584825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]